Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
represents the hepatic expression of several metabolic abnormalities of high epidemiologic …

Unhealthy dietary patterns-induced obesity and obesity-related complications pose a great
threat to human health all over the world. Accumulating evidence suggests that the …

Metabolic dysfunction-associated fatty liver disease (MAFLD) is among the most widespread
metabolic disease globally, and its associated complications including insulin resistance …

Lipid droplets (LDs) were considered as a mere lipid storage organelle for a long time.
Recent evidence suggests that LDs are in fact distinct and dynamic organelles with a …

Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as the presence of
hepatic steatosis in addition to one of three metabolic conditions: overweight/obesity, type 2 …

Quercetin, a polyphenol widely present in the plant kingdom, has received great interest due
to pleiotropic effects. As evidenced by animal and cellular studies, quercetin exerts …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly termed
nonalcoholic fatty liver disease (NAFLD), is a widespread global health concern that affects …

Non-alcoholic fatty liver disease (NAFLD) has increasingly become a serious public health
problem. There is growing evidence that nonylphenol (NP) exposure may cause steatosis …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-
alcoholic fatty liver disease, is characterized by hepatic steatosis and metabolic dysfunction …